RE:LP's by patient countPatient counts really do not matter as much as you would think. The patients swing back and forth. Patients try a LP, find they don't like the product and then try another. And generally, patients have to renew their status/script on a 1-3 month basis, at which point they will tend to try another LP to see what their product is like.
The real story is on the pending rec user - this and many other MJ stocks will experience a lift between now and when the dust settles after legislation in Canada and potentially abroad - ie: Brazil, Germany and Austrialia - which CGC has interests in each of these markets.
Dont' get me wrong, at the moment, CGC is dependant upon their subscriber base, but they are looking ahead too whereby their subscriber base will account for a very small percentage of their overall revenue. CGC is well positioned to be a leader in this space and are making moves to be the dominant player, but many others are also in the same head space.
The real story in the immediate future will be the Aug 24 ruling, but there will be hills ad valleys along the eway, this is at least a 10-18 month play that will really sow what this industry is all about. Till then we ride the wave and the wave keeps getting bigger and bigger.